Different severity scores have different strengths and weaknesses as prediction tools. Validation should be done in the most relevant clinical setting, using more appropriate constructs of "severe pneumonia" to ensure that these potentially useful tools truly deliver what clinicians expect of them.
No takes yet. Share an insight, caveat, or question.
Kirsty Buising (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: